May 24, 2016

Posted by in Stock Reports | 0 Comments

Latest Insider Sales: Breitburn Energy Partners LP (NASDAQ:BBEP), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Spark Therapeutics (NASDAQ:ONCE)

Latest Insider Sales: Breitburn Energy Partners LP (NASDAQ:BBEP), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Spark Therapeutics (NASDAQ:ONCE)

As a general rule, insider buying shows management’s confidence in the company, and is considered a bullish sign—in other words a sign that stock prices are likely to go up. Conversely, insider selling is considered bearish—those in the know may be off loading their stocks in an expectation that prices will soon fall. So it pays to keep an eye on the activities of insiders.

Studies have shown that prompt and timely dissemination of insider transactions are profitable for investors, as insiders tend to beat the market. The odds in favor of an insider purchase being followed by further purchases are three times greater than the odds of a purchase followed by a sale.

Breitburn Energy Partners LP (NASDAQ:BBEP) saw an insider sell on May 20, 2016 that may make shareholders worried. Moroney Gregory J, director, sold 51,852 shares at $0.07 a piece. The total sale came to $3,578, leaving the total count to 3,000 shares. Its shares currently owned by company management are 1.20% while institutional investors own about 22.20%. The 6-month change recorded in total insider ownership was -8.99%. On the other side, 412.99% change in total institutional ownership has been reported for the 3-month period.

Moving on to the second insider trade which involved Tessmer James F, a VP, Finance & Accounting at Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) sold 6,000 shares at $6.23 per share to trim the total holding at 21,946 shares. Its shares currently owned by company management are 0.20% while institutional investors own about 95.20%. The 6-month change recorded in total insider ownership was -2.81%. On the other side, 0.96% change in total institutional ownership has been reported for the 3-month period.

Spark Therapeutics Inc (NASDAQ:ONCE) also received some insider trading action as Marrazzo Jeffrey D, who the company’s Chief Executive Officer is sold some 25,000 shares at a price of $46.01 per share to the holding that now comprises of 230,000 shares. Its shares currently owned by company management are 29.60% while institutional investors own about 79.40%. The 6-month change recorded in total insider ownership was -13.72%. On the other side, 7.40% change in total institutional ownership has been reported for the 3-month period.

Comments are closed.